233 related articles for article (PubMed ID: 17482720)
1. Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
Grieco P; Cai M; Han G; Trivedi D; Campiglia P; Novellino E; Hruby VJ
Peptides; 2007 Jun; 28(6):1191-6. PubMed ID: 17482720
[TBL] [Abstract][Full Text] [Related]
2. Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
Grieco P; Balse-Srinivasan P; Han G; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
J Pept Res; 2003 Nov; 62(5):199-206. PubMed ID: 14531843
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors.
Grieco P; Lavecchia A; Cai M; Trivedi D; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
J Med Chem; 2002 Nov; 45(24):5287-94. PubMed ID: 12431055
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6.
Grieco P; Han G; Weinberg D; Van der Ploeg LH; Hruby VJ
Biochem Biophys Res Commun; 2002 Apr; 292(4):1075-80. PubMed ID: 11944925
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
[TBL] [Abstract][Full Text] [Related]
6. Structure activity studies of the melanocortin antagonist SHU9119 modified at the 6, 7, 8, and 9 positions.
Haskell-Luevano C; Lim S; Yuan W; Cone RD; Hruby VJ
Peptides; 2000 Jan; 21(1):49-57. PubMed ID: 10704719
[TBL] [Abstract][Full Text] [Related]
7. Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.
Mayorov AV; Cai M; Chandler KB; Petrov RR; Van Scoy AR; Yu Z; Tanaka DK; Trivedi D; Hruby VJ
J Med Chem; 2006 Mar; 49(6):1946-52. PubMed ID: 16539382
[TBL] [Abstract][Full Text] [Related]
8. Biological and conformational study of beta-substituted prolines in MT-II template: steric effects leading to human MC5 receptor selectivity.
Cai M; Cai C; Mayorov AV; Xiong C; Cabello CM; Soloshonok VA; Swift JR; Trivedi D; Hruby VJ
J Pept Res; 2004 Feb; 63(2):116-31. PubMed ID: 15009533
[TBL] [Abstract][Full Text] [Related]
9. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
[TBL] [Abstract][Full Text] [Related]
11. Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.
Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
J Med Chem; 2007 May; 50(10):2520-6. PubMed ID: 17455928
[TBL] [Abstract][Full Text] [Related]
12. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
13. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
14. Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors.
Kavarana MJ; Trivedi D; Cai M; Ying J; Hammer M; Cabello C; Grieco P; Han G; Hruby VJ
J Med Chem; 2002 Jun; 45(12):2644-50. PubMed ID: 12036373
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor.
Mayorov AV; Cai M; Palmer ES; Dedek MM; Cain JP; Van Scoy AR; Tan B; Vagner J; Trivedi D; Hruby VJ
J Med Chem; 2008 Jan; 51(2):187-95. PubMed ID: 18088090
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor.
Ying J; Gu X; Cai M; Dedek M; Vagner J; Trivedi DB; Hruby VJ
J Med Chem; 2006 Nov; 49(23):6888-96. PubMed ID: 17154518
[TBL] [Abstract][Full Text] [Related]
17. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
18. Design of novel melanotropin agonists and antagonists with high potency and selectivity for human melanocortin receptors.
Cai M; Mayorov AV; Ying J; Stankova M; Trivedi D; Cabello C; Hruby VJ
Peptides; 2005 Aug; 26(8):1481-5. PubMed ID: 15876475
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
[TBL] [Abstract][Full Text] [Related]
20. Structural Insights into Selective Ligand-Receptor Interactions Leading to Receptor Inactivation Utilizing Selective Melanocortin 3 Receptor Antagonists.
Cai M; Marelli UK; Mertz B; Beck JG; Opperer F; Rechenmacher F; Kessler H; Hruby VJ
Biochemistry; 2017 Aug; 56(32):4201-4209. PubMed ID: 28715181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
